Light-activated azobenzene peptide inhibitor of the PD-1/PD-L1 interaction

Hayward, Deanne, Goddard, Zoë R. ORCID: https://orcid.org/0000-0002-7900-1553, Cominetti, Marco M. D., Searcey, Mark ORCID: https://orcid.org/0000-0003-2273-8949 and Beekman, Andrew M. ORCID: https://orcid.org/0000-0002-3056-6406 (2024) Light-activated azobenzene peptide inhibitor of the PD-1/PD-L1 interaction. Chemical Communications, 60 (63). pp. 8228-8231. ISSN 1359-7345

[thumbnail of Hayward_etal_2024_ChemComm_d4cc01249f]
Preview
PDF (Hayward_etal_2024_ChemComm_d4cc01249f) - Published Version
Available under License Creative Commons Attribution.

Download (955kB) | Preview

Abstract

Inhibiting the PD-1/PD-L1 protein–protein interaction is a key immunotherapy for cancer. Antibodies dominate the clinical space but are costly, with limited applicability and immune side effects. We developed a photo-controlled azobenzene peptide that selectively inhibits the PD-1/PD-L1 interaction when in the cis isomer only. Activity is demonstrated in in vitro and cellular assays.

Item Type: Article
Additional Information: Funding information: The authors acknowledge support from Big C Cancer Charity (19-13R) and the Royal Society (RGS\R1\201008). Mass spectrometry was supported by BBSRC (BB/T017708/1).
Uncontrolled Keywords: electronic, optical and magnetic materials,ceramics and composites,metals and alloys,materials chemistry,surfaces, coatings and films,chemistry(all),catalysis,sdg 3 - good health and well-being ,/dk/atira/pure/subjectarea/asjc/2500/2504
Faculty \ School: Faculty of Science
Faculty of Science > School of Pharmacy (former - to 2024)
UEA Research Groups: Faculty of Medicine and Health Sciences > Research Centres > Norwich Institute for Healthy Aging
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 16 Jul 2024 08:32
Last Modified: 14 Aug 2024 03:30
URI: https://ueaeprints.uea.ac.uk/id/eprint/95933
DOI: 10.1039/D4CC01249F

Downloads

Downloads per month over past year

Actions (login required)

View Item View Item